|
|
Molecular mechanisms of prostate cancer metastasis
|
5R01CA183929-02
|
$366,000
|
$366,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The role of exRNA in Health Disparity of Prostate Cancer
|
5R21CA194750-02
|
$162,426
|
$81,213
|
ABD ELMAGEED, ZAKARIA
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
Role of NFxB/HIF2a axis in renal cell carcinoma progression
|
4K08CA178168-04
|
$175,163
|
$87,582
|
ABEL, E
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages
|
5R01CA172105-02
|
$401,456
|
$401,456
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy
|
5U01CA142565-08
|
$462,791
|
$462,791
|
ABRAMSON, RICHARD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Defining mechanisms of cancer chemoresistance and metastasis
|
5R00CA172697-04
|
$246,504
|
$246,504
|
ACHARYYA, SWARNALI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Center for Multiple Myeloma Nanotherapy
|
3U54CA199092-01S1
|
$27,659
|
$15,766
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
|
Center for Multiple Myeloma Nanotherapy
|
3U54CA199092-02S1
|
$57,523
|
$32,788
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-02
|
$2,230,648
|
$1,271,469
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
|
2U54CA163069-06
|
$1,401,481
|
$266,281
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
|
Platelets promote growth of ovarian cancer
|
4R01CA177909-04
|
$332,000
|
$166,000
|
AFSHAR-KHARGHAN, VAHID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
ANALYSIS AND THERAPEUTIC TARGETING OF BREAST CANCER DISSEMINATED TUMOR CELLS
|
4R01CA172623-04
|
$388,953
|
$388,953
|
AFT, REBECCA
|
WASHINGTON UNIVERSITY
|
|
|
High Throughput Mechanical Modulatory Assay for Breast Cancer Drug Testing
|
1R21CA210126-01
|
$186,775
|
$186,775
|
AGAH, MASOUD
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
|
|
Fat transplant for glitazone delivery and adiponectin production to inhibit breast cancer
|
5R21CA187829-02
|
$194,445
|
$97,223
|
AGARWAL, JAYANT
|
UNIVERSITY OF UTAH
|
|
|
Functional Determinants of Metastatic Dormancy
|
2R01CA109182-13
|
$436,677
|
$436,677
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
|
Organ specific macrophages and the regulation of disseminated tumor cell fate
|
5R03CA191430-02
|
$84,750
|
$84,750
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
|
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis
|
4R01CA180149-04
|
$560,735
|
$560,735
|
AGUS, DAVID
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
1R01CA197081-01A1
|
$440,786
|
$145,459
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Targeting galectin-3 for prostate cancer therapy
|
1R43CA203420-01
|
$224,881
|
$224,881
|
AHMED, HAFIZ
|
GLYCOMANTRA, INC.
|
|
|
Targeting galectin-3 for prostate cancer therapy
|
3R43CA203420-01S1
|
$40,000
|
$40,000
|
AHMED, HAFIZ
|
GLYCOMANTRA, INC.
|
|
|
SON and the MALAT1 locus in chromatin interaction and metastasis gene regulation
|
5R21CA185818-02
|
$164,756
|
$164,756
|
AHN, ERIN
|
UNIVERSITY OF SOUTH ALABAMA
|
|
|
Elucidating the role and regulation of epithelial plasticity in metastasis
|
5F31CA177163-03
|
$30,341
|
$30,341
|
AIELLO, NICOLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Post-translational control of cancer cell stress response and metastasis
|
1R01CA202027-01A1
|
$445,437
|
$445,437
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-08S1
|
$244,135
|
$26,855
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-08S2
|
$124,997
|
$13,750
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-08S3
|
$109,572
|
$12,053
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-08S4
|
$104,650
|
$11,512
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
5P30CA138313-08
|
$2,093,000
|
$230,230
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
The Partnership for Native American Cancer Prevention (2 of 2)
|
3U54CA143924-08S1
|
$52,166
|
$2,087
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
The Partnership for Native American Cancer Prevention (2 of 2)
|
5U54CA143924-08
|
$1,383,238
|
$55,330
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
p90RSK2-Stathmin Signaling in Metastatic Human Cancers
|
5F31CA183365-03
|
$43,576
|
$43,576
|
ALESI, GINA
|
EMORY UNIVERSITY
|
|
|
Single-Cell Measurement of Lipid Signaling in Colorectal Cancer
|
5R01CA177993-03
|
$590,158
|
$590,158
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
Interleukin-4 Drives Tumor-Associated Macrophage Polarization to Promote Tumor Gr
|
4F30CA173910-03
|
$48,576
|
$48,576
|
ALLEN, STEVEN
|
UNIVERSITY OF MICHIGAN
|
|
|
INFLAMMATORY CHEMOKINE CCL3 IN THE TUMOR MICROENVIRONMENT LEADS TO ENHANCED ANTITUMOR IMMUNE DEVELOPMENT IN THE DRAINING LYMPH NODE
|
5F31CA192874-03
|
$31,560
|
$15,780
|
ALLEN, FREDERICK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
|
5R01CA198074-02
|
$384,048
|
$192,024
|
ALLEN, BENJAMIN
|
UNIVERSITY OF MICHIGAN
|
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-03
|
$435,560
|
$108,890
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
|
Novel Molecular Therapies of Prostate Cancer
|
2P01CA140043-07A1
|
$1,272,322
|
$1,272,322
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-47S1
|
$142,498
|
$35,625
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-47
|
$2,645,581
|
$661,395
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Control of Apoptosis in Cancer by Survivin
|
5R01CA078810-19
|
$380,000
|
$380,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
(PQC2) Plasticity Of The.PI3K Network In Early Dormancy
|
5R01CA190027-03
|
$394,250
|
$130,103
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
|
5R01CA178610-03
|
$316,934
|
$158,467
|
ALUMKAL, JOSHI
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence
|
1R01CA208042-01
|
$363,713
|
$120,025
|
ALVAREZ, JAMES
|
DUKE UNIVERSITY
|
|
|
HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition
|
4R01CA169134-04
|
$312,942
|
$156,471
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Role of Splicing Factors in Breast Cancer
|
4R00CA178206-03
|
$249,000
|
$249,000
|
ANCZUKOW-CAMARDA, OLGA
|
JACKSON LABORATORY
|
|
|
Enhancing prognostic power of tumor grade by revisiting Ki67-mitosis relationship
|
5R03CA188527-02
|
$74,000
|
$74,000
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
|
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
|
5U01CA179671-03
|
$307,100
|
$307,100
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
|
Nuclear Factor-kappaB in Ovarian Cancer
|
ZIA BC 011054
|
$613,716
|
$122,743
|
Annunziata, Christina
|
CCR (NCI)
|
|
|
Non-canonical functions of EZH2 in triple-negative breast cancer
|
5F30CA196084-02
|
$34,177
|
$34,177
|
ANWAR, TALHA
|
UNIVERSITY OF MICHIGAN
|
|
|
Mutant BRAF-regulated transcription factors in melanoma progression
|
5R01CA196278-02
|
$356,850
|
$356,850
|
APLIN, ANDREW
|
THOMAS JEFFERSON UNIVERSITY
|
|
Total relevant funding to Metastasis for this search: $409,622,279
|
